Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

AFib ablation during CABG | Cardiologists are first in world to use cooling device | A new 2D ICE catheter launches

News You Need to Know Today
AFib ablation during CABG | Cardiologists are first in world to use cooling device | A new 2D ICE catheter launches
Monday, June 23, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Heart Rhythm

AFib ablation during CABG improves survival

Clinical guidelines already recommend that these procedures be performed together when applicable. However, researchers noted, it is still not terribly common among today’s surgeons. 

READ MORE >
CABG coronary artery bypass grafting heart surgery
Share on Twitter Share on Facebook Share on Linkedin

AFib ablation during CABG improves survival

Share on Twitter Share on Facebook Share on Linkedin
CABG coronary artery bypass grafting heart surgery
Clinical guidelines already recommend that these procedures be performed together when applicable. However, researchers noted, it is still not terribly common among today’s surgeons. 
READ MORE >

Cardiologists are first in world to use new cooling device to terminate AFib during surgery

Patients often develop AFib during cardiac surgery, leading to longer hospital stays, additional healthcare costs and a higher risk of mortality. Cooling the oblique sinus of the patient's heart as soon as AFib starts to develop may represent a new way to stop the problem in its tracks. 

READ MORE >
heart ice cool cold freezing frozen
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists are first in world to use new cooling device to terminate AFib during surgery

Share on Twitter Share on Facebook Share on Linkedin
heart ice cool cold freezing frozen
Patients often develop AFib during cardiac surgery, leading to longer hospital stays, additional healthcare costs and a higher risk of mortality. Cooling the oblique sinus of the patient's heart as soon as AFib starts to develop may represent a new way to stop the problem in its tracks. 
READ MORE >

Johnson & Johnson MedTech launches new 2D ICE catheter

The company says the new device was designed to improve image quality, provide additional maneuverability and simplify ablation workflows for electrophysiologists. 

READ MORE >
 SoundStar Crystal Ultrasound Catheter Johnson & Johnson MedTech
Share on Twitter Share on Facebook Share on Linkedin

Johnson & Johnson MedTech launches new 2D ICE catheter

Share on Twitter Share on Facebook Share on Linkedin
 SoundStar Crystal Ultrasound Catheter Johnson & Johnson MedTech
The company says the new device was designed to improve image quality, provide additional maneuverability and simplify ablation workflows for electrophysiologists. 
READ MORE >

Atraverse Medical raises $29M to support FDA-approved heart tech

The San Diego-based startup gained FDA approval for its Hotwire RF guidewire in 2024. The technology has already been used to perform hundreds of heart procedures.

READ MORE >
money business cash flow dollar. Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The transaction was funded with $5.4 million in cash and $5.6 million in debt financing.
Share on Twitter Share on Facebook Share on Linkedin

Atraverse Medical raises $29M to support FDA-approved heart tech

Share on Twitter Share on Facebook Share on Linkedin
money business cash flow dollar. Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The transaction was funded with $5.4 million in cash and $5.6 million in debt financing.
The San Diego-based startup gained FDA approval for its Hotwire RF guidewire in 2024. The technology has already been used to perform hundreds of heart procedures.
READ MORE >

World’s first leadless LBBAP procedures linked to ‘promising’ outcomes

Cardiologists are turning to leadless pacemakers more and more for cardiac pacing, but those devices have not previously been able to perform LBBAP. This new analysis includes new data on the world’s very first leadless LBBAP procedures. 

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

World’s first leadless LBBAP procedures linked to ‘promising’ outcomes

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Cardiologists are turning to leadless pacemakers more and more for cardiac pacing, but those devices have not previously been able to perform LBBAP. This new analysis includes new data on the world’s very first leadless LBBAP procedures. 
READ MORE >

Bayer's finerenone reduces risk of AFib, atrial flutter in all CKM syndrome patients

New data published in JACC represents another big win for Bayer's finerenone. The drug has previously been linked to cardiovascular benefits for patients with CKD and heart failure, but its potential across the full CKM spectrum remained a bit of a mystery.

READ MORE >
doctor with overweight patient who may be treated with TAVR or surgery
Share on Twitter Share on Facebook Share on Linkedin

Bayer's finerenone reduces risk of AFib, atrial flutter in all CKM syndrome patients

Share on Twitter Share on Facebook Share on Linkedin
doctor with overweight patient who may be treated with TAVR or surgery
New data published in JACC represents another big win for Bayer's finerenone. The drug has previously been linked to cardiovascular benefits for patients with CKD and heart failure, but its potential across the full CKM spectrum remained a bit of a mystery.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Supreme Court sides supports cardiac drug maker | X-ray assesses pulmonary valve regurgitation | Making cardiac data actionable
Week in Review: Former ACC president dies | Administration questions vascular care | Is coffee bad for the heart | FFR-CT guide
New-look pacemaker uses ultrasound to stimulate the heart | Heartflow reports significant revenue growth | CCTA & CTO PCI
New FFR-CT standardization consensus document | FDA clears first tricupid surgical valve | ECG AI to detect amyloidosis
Shockwave Medical's new IVL catheter | BATMAN to the rescue | Antiplatelet drugs after PCI | FDA announces recalls
When TAVR patients require surgery later in life | Colleagues pay tribute to a cardiology powerhouse | Much more
TAVR Highlights: Self-expanding valves continue to impress | A new technique | Why implant depth matters | SAPT vs. DAPT

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup